The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 27, 2024

Filed:

Dec. 07, 2017
Applicants:

Merck Sharp & Dohme Llc, Rahway, NJ (US);

Beijing Genomics Institute AT Shenzhen, Guangdong, CN;

Inventors:

Peter M. Shaw, Yardley, PA (US);

Devan V. Mehrotra, Lansdale, PA (US);

Rebecca L. Blanchard, Allentown, PA (US);

Judong Shen, Westfield, NJ (US);

Robin Mogg, Chalfont, PA (US);

Mary Beth Dorr, Collegeville, PA (US);

Junhua Li, Shenzhen, CN;

Xun Xu, Shenzhen, CN;

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12Q 1/6876 (2018.01); A61K 31/4164 (2006.01); A61K 31/7048 (2006.01); A61K 38/14 (2006.01); A61K 39/40 (2006.01); A61P 31/04 (2006.01); C07K 16/12 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6876 (2013.01); A61K 31/4164 (2013.01); A61K 31/7048 (2013.01); A61K 38/14 (2013.01); A61K 39/40 (2013.01); A61P 31/04 (2018.01); C07K 16/1282 (2013.01); C07K 2317/565 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/156 (2013.01);
Abstract

The present invention provides genetic markers on human chromosome 6 that are associated with a beneficial response to a treatment that targets() toxin B (TcdB), e.g. a TcdB antibody. These TcdB treatment response markers are useful, inter alia, to identify patients who are most likely to benefit from treatment that targets TcdB in methods of treating patients having a disease susceptible to treatment with a TcdB antibody, and in methods for selecting the most appropriate therapy for such patients. The invention also provides antibodies, drug products, and kits useful with the TcdB Treatment response markers of the invention.


Find Patent Forward Citations

Loading…